Skip to main content
Loading market data...
ETF NYSE Arca USD

Simplify Propel Opportunities ETF SURI

Issuer: Simplify SEC registrant: Simplify Exchange Traded Funds Multi-asset · US
Last price 16.85 USD Change: Up +0.32 Percent change: Up +1.93%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Net expense ratio
2.56%
Prospectus 19 May 2026
Net assets
$77.3M
As of 30 Jun 2026
Holdings
39
As of 30 Jun 2026
12-month distribution yield
16.14%
Quarterly
Asset class
Multi-asset
From holdings

Simplify Propel Opportunities ETF (SURI) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Simplify. Its category is Multi-asset · US (multi-asset). Its last price was US$16.85 on 20 Oct 2026. Its net expense ratio is 2.56% a year, from its prospectus dated 19 May 2026. It reported net assets of US$77.25 million as of 30 Jun 2026. Its latest holdings report lists 39 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$2.72 a unit, a 12-month distribution yield of 16.14%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
2.81%
Net, after fee waivers or reimbursements
2.56%
Management fee
2.75%
Prospectus date
19 May 2026
Filed with the SEC
18 May 2026

Size and reporting

Net assets
$77,252,814
Total assets
$135,734,764
Holdings as of
30 Jun 2026
Report made public
24 Aug 2026 (55 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 39 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.

SURI top holdings as of 30 Jun 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT B 0 10/20/26 US912797VM69 76.77% $59.3M Debt United States USD
2 MORGAN STANLEY & CO. LLC No identifier reported -75.22% -$58.1M Repurchase agreements United States USD
3 PLAINS GP HOLDINGS LP PLAINS GP HOLDINGS LP LTD PARTNR INT A US72651A2078 39.97% $30.9M Equity (common) United States USD
4 ACHIEVE LIFE SCIENCES INC ACHIEVE LIFE SCIENCES INC COM US0044685008 12.11% $9.4M Equity (common) United States USD
5 MILESTONE PHARMACEUTICALS INC MILESTONE PHARMACEUTICALS INC COM CA59935V1076 5.81% $4.5M Equity (common) Canada USD
6 ACHIEVE LIFE SCIENCES INC ACHIEVE LIFE SCIENCES INC WT EXP 063030 US0044681874 4.42% $3.4M Equity (common) United States USD
7 DELCATH SYSTEMS INC DELCATH SYSTEMS INC COM NEW US24661P8077 4.26% $3.3M Equity (common) United States USD
8 PHATHOM PHARMACEUTICALS INC PHATHOM PHARMACEUTICALS INC COM US71722W1071 3.50% $2.7M Equity (common) United States USD
9 CORCEPT THERAPEUTICS INC CORCEPT THERAPEUTICS INC COM US2183521028 2.98% $2.3M Equity (common) United States USD
10 ABEONA THERAPEUTICS INC ABEONA THERAPEUTICS INC COM NEW US00289Y2063 2.76% $2.1M Equity (common) United States USD
11 CELLDEX THERAPEUTICS INC CELLDEX THERAPEUTICS INC COM NEW US15117B2025 2.56% $2.0M Equity (common) United States USD
12 KYVERNA THERAPEUTICS INC KYVERNA THERAPEUTICS INC COM US5019761049 2.11% $1.6M Equity (common) United States USD
13 COMPASS PATHWAYS PLC COMPASS PATHWAYS PLC SPONSORED ADS US20451W1018 2.09% $1.6M Equity (common) United Kingdom USD
14 LEONABIO INC LEONABIO INC COM US04746L2034 1.78% $1.4M Equity (common) United States USD
15 INVENTIVA SA INVENTIVA SA ADS US46124U1079 1.53% $1.2M Equity (common) France USD
16 AQUESTIVE THERAPEUTICS INC AQUESTIVE THERAPEUTICS INC COM US03843E1047 1.50% $1.2M Equity (common) United States USD
17 ARTIVA BIOTHERAPEUTICS INC ARTIVA BIOTHERAPEUTICS INC COM US04317A1079 1.27% $983K Equity (common) United States USD
18 ZEVRA THERAPEUTICS INC ZEVRA THERAPEUTICS INC COM NEW US4884452065 1.25% $966K Equity (common) United States USD
19 ORCHESTRA BIOMED HOLDINGS INC ORCHESTRA BIOMED HOLDINGS INC COM US68572M1062 1.23% $947K Equity (common) United States USD
20 PALISADE BIO INC PALISADE BIO INC COM US6963894026 1.22% $942K Equity (common) United States USD
21 TELESAT CANADA / TELESAT LLC TELSAT 5.625 12/06/26 144A US87952VAR78 1.16% $895K Debt Canada USD
22 OCULAR THERAPEUTIX INC OCULAR THERAPEUTIX INC COM US67576A1007 1.03% $796K Equity (common) United States USD
23 ACHIEVE LIFE SCIEN RTS No identifier reported 0.97% $748K Equity (common) United States USD
24 EYEPOINT INC EYEPOINT INC COM NEW US30233G2093 0.84% $649K Equity (common) United States USD
25 IMMUNIC INC IMMUNIC INC COM NEW US4525EP2001 0.61% $472K Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 97.77%
Debt 77.92%
Repurchase agreements -75.22%

Country

Country by weight
CountryWeightBar
United States 89.87%
Canada 6.97%
United Kingdom 2.09%
France 1.53%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 100.47%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Energy 39.97%
Health Care 4.01%
Health Technology 0.55%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$2.7200
4 payments per unit
12-month yield
16.14%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
25 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($2.7200) ÷ latest price ($16.85) × 100 = 16.14%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (15 payments)
SURI distributions per unit by ex-date
Ex-dateAmount per unit
25 Sep 2026$0.6800
25 Jun 2026$0.6800
26 Mar 2026$0.6800
23 Dec 2025$0.6800
25 Sep 2025$0.6800
25 Jun 2025$0.6800
26 Mar 2025$0.6800
23 Dec 2024$0.6800
25 Sep 2024$0.6800
25 Jun 2024$1.2500
25 Mar 2024$0.6800
26 Dec 2023$0.6800
27 Sep 2023$0.6800
27 Jun 2023$0.6800
27 Mar 2023$1.0000

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme